Organization
AbbVie Deutschland GmbH & Co KG
3 abstracts
Abstract
ADALIMUMAB IN PATIENTS WITH ACTIVE AND INACTIVE, NON-INFECTIOUS UVEITIS: VISUAL I AND VISUAL II TRIALS Org: AbbVie GK Japan, AbbVie Inc., North Chicago, IL, AbbVie Deutschland GmbH & Co KG, AbbVie, Inc., North Chicago, United States of America, Truhlsen Eye Institute, University of Nebraska Medical Center,
Abstract
ACHIEVING COMPREHENSIVE DISEASE CONTROL IN LONG-STANDING OR EARLY RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ADALIMUMAB PLUS METHOTREXATE VERSUS METHOTREXATE ALONE Org: AbbVie, Leiden University Medical Center, The Karolinska Institute, Stockholm, Sweden, AbbVie Inc., North Chicago, IL, AbbVie Deutschland GmbH & Co KG,
Abstract
ADALIMUMAB IN PATIENTS WITH ACTIVE, NON-INFECTIOUS UVEITIS REQUIRING HIGH-DOSE CORTICOSTEROIDS: THE VISUAL-1 TRIAL Org: AbbVie Inc., North Chicago, IL, AbbVie Deutschland GmbH & Co KG, Laura Bassi Centre of Expertise Ocuvac, Organizaciόn Médica de Investigaciόn (OMI),